Sign in

CIK 0001124105

  • Accelerated filer
  • Smaller reporting company

GYRE THERAPEUTICS, INC.

Sign in to watch
Ticker
GYRE
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
562020050
Phone
+1 858-284-0115
Business address
12730 HIGH BLUFF DRIVE, SUITE 250, SAN DIEGO, CA, 92130
Former names
CATALYST BIOSCIENCES, INC., TARGACEPT INC
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2016-06-09 USMAN NASSIM President and CEO Other acquisition · Stock Option (Right to Buy) +0 0
2016-06-09 USMAN NASSIM President and CEO Grant or award · Stock Option (Right to Buy) +7,500 7,500
2016-06-09 SELICK HAROLD E Director Grant or award · Stock Option (Right to Buy) +7,500 7,500
2016-06-09 Richard John P Director Grant or award · Stock Option (Right to Buy) +7,500 7,500
2016-06-09 LAWLOR AUGUSTINE Director Grant or award · Stock Option (Right to Buy) +7,500 7,500
2016-06-09 HILL STEPHEN A Director Grant or award · Stock Option (Right to Buy) +7,500 7,500
2016-06-09 DESOUZA ERROL B Director Grant or award · Stock Option (Right to Buy) +7,500 7,500
2016-04-18 Levy Howard Chief Medical Officer Grant or award · Stock Option (Right to Buy) +100,000 100,000
2015-12-17 USMAN NASSIM President & CEO Purchase +4,000 $2.00 $8K 78,375
2015-12-17 Payne Fletcher Chief Financial Officer Purchase +10,000 $2.00 $20K 25,032
2015-12-17 HILL STEPHEN A Director Purchase +5,000 $2.03 $10K 20,711
2015-10-22 USMAN NASSIM President & CEO Grant or award · Stock Option (Right to Buy) +153,572 153,572
2015-10-22 SELICK HAROLD E Director Grant or award · Stock Option (Right to Buy) +6,750 6,750
2015-10-22 Richard John P Director Grant or award · Stock Option (Right to Buy) +6,750 6,750
2015-10-22 Payne Fletcher Chief Financial Officer Grant or award · Stock Option (Right to Buy) +28,572 28,572
2015-10-22 Madison Edwin Chief Scientific Officer Grant or award · Stock Option (Right to Buy) +58,572 58,572
2015-10-22 LAWLOR AUGUSTINE Director Grant or award · Stock Option (Right to Buy) +6,750 6,750
2015-10-22 HILL STEPHEN A Director Grant or award · Stock Option (Right to Buy) +6,750 6,750
2015-10-22 DESOUZA ERROL B Director Grant or award · Stock Option (Right to Buy) +6,750 6,750
2015-10-22 LAWLOR AUGUSTINE Director Grant or award · Stock Option (Right to Buy) +8,250 8,250

Page 23 of 24 · 471 trades